FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AnazaoHealth B-Complex Recall

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI inje…

AnazaoHealth Corporation · Las Vegas, NV

Risk level
Class II
Reported by FDA
Jan 3, 2024
Recall ID
D-0203-2024
Check your lot numberHow we source this data

Summary

AnazaoHealth recalled B-Complex starting Nov 22, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0203-2024 on Jan 3, 2024. Reason: Presence of Particulate Matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter.

Product description

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Lot numbers, UPCs & expiration codes

Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0203-2024
Classification
Class II
Status
Terminated
Recall initiated
Nov 22, 2023
FDA report date
Jan 3, 2024
Quantity
5,707 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AnazaoHealth Corporation

Original FDA data

Every field from FDA enforcement report D-0203-2024, exactly as published.

Show all FDA fields
City
Las Vegas
State
NV
Status
Terminated
Country
United States
Event ID
93500
Address
7465 W Sunset Rd Ste 1200
Code information
Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24
Postal code
89113-1944
Report date
Jan 3, 2024
Product type
Drugs
Recall number
D-0203-2024
Classification
Class II
Recalling firm
AnazaoHealth Corporation
Product quantity
5,707 vials
Termination date
Sep 29, 2025
Reason for recall
Presence of Particulate Matter.
Voluntary / mandated
Voluntary: Firm initiated
Product description
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
Distribution pattern
Nationwide in the USA.
Recall initiation date
Nov 22, 2023
Initial firm notification
Letter
Center classification date
Dec 26, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0203-2024, published Jan 3, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls